Clinical Trials Logo
  1. Home
  2. Substance Use Disorders
  3. NCT05889702
  4. Details
NCT05889702 Clinical Trial

Kentucky Access to Recovery Evaluation

Substance Use Disorders Clinical Trial

Official title:
Evaluation of the Kentucky Access to Recovery (KATR) Linkage Strategy

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT05889702
Other study ID # 81811
Secondary ID R01CE003513-01-0
Status Active, not recruiting
Phase
First received
Last updated
Start date July 3, 2023
Est. completion date December 2024

Study information
Verified date April 2024
Source University of Kentucky
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Evaluate the long-term effectiveness of implementing vouchers as a linkage strategy in a population requiring recovery support services (RSS) when no other funding sources are available. A within-subjects study design will be used to test the effectiveness of the Kentucky Access to Recovery (KATR) last resort voucher linkage approach to reduce the risk of nonfatal and fatal overdoses by (a) increasing an individual's recovery capital; (b) reducing resumption of illicit substance use; and (c) promoting relinking to RSSs if illicit substance use is resumed.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 300
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - be in SUD treatment or have completed within the past year SUD treatment for opioid use disorder or stimulant use disorder or have a history of overdose from opioid use - be a first-time participant in KATR - be in early stages of recovery (less than one year in recovery) - be a resident of a KATR service county - be at or below the 200% federal poverty level - not have financial resources available through other funding mechanisms for RSSs - be 18 years of age and older - be in need of recovery supports that will enhance their likelihood of staying in recovery Exclusion Criteria: - Under 18 - Participated in KATR previously

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• KATR Linkage Strategy
The Kentucky ATR (KATR) strategy is a 25-county program that links county residents at or below the 200% national poverty level who have an illicit SUD and are in treatment or early recovery to evidence-based RSSs such as recovery housing, and to other RSSs. The KATR linkage approach uses vouchers as a linkage strategy for individuals in SUD treatment who have no other funding options to acquire critical RSSs. As such, KATR's linkage through vouchers is a "last resort" approach for linking to RSSs.

Locations
Country Name City State
United States FAHE Berea Kentucky
United States University of Kentucky Lexington Kentucky

Sponsors (1)
Lead Sponsor Collaborator
Terry Bunn

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in Recovery Capital per person Recovery capital will be assessed using the Brief Assessment of Recovery Capital-10 (BARC-10); 10 item survey unidimensional measure of recovery capital, scores may range from 6-60 at any given time. Evaluation of the measure suggests that individuals who have a higher score are likely to reach or sustain a year or longer of recovery from substance use disorder. Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
Primary Change in number of drug overdoses per person Number of drug overdoses will be assessed with the following survey question: In the past 30 days, did you experience an overdose or take too much of a substance that resulted in needing supervision or medical attention? Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
Primary Change in number of days of illicit substance use per person Number of days illicit substance use will be assessed with the following survey question: During the past 30 days, how many days have you used any substance Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT05660434 - Using Aromatherapy in Substance Use Disorder N/A
Recruiting NCT05338268 - Substance Use and Loneliness N/A
Completed NCT03954184 - E-health Implementation (Iowa) N/A
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Active, not recruiting NCT04048850 - Zepatier in Patients With Substance Use
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2